- Home
- ESPR vs NCV Comparison
ESPR vs NCV Comparison
Compare ESPR & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NCV
- Stock Information
- Founded
- ESPR 2008
- NCV 2003
- Country
- ESPR United States
- NCV United States
- Employees
- ESPR N/A
- NCV N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NCV Finance Companies
- Sector
- ESPR Health Care
- NCV Finance
- Exchange
- ESPR Nasdaq
- NCV Nasdaq
- Market Cap
- ESPR 305.0M
- NCV 299.1M
- IPO Year
- ESPR 2013
- NCV N/A
- Fundamental
- Price
- ESPR $1.50
- NCV $13.02
- Analyst Decision
- ESPR Buy
- NCV
- Analyst Count
- ESPR 7
- NCV 0
- Target Price
- ESPR $6.36
- NCV N/A
- AVG Volume (30 Days)
- ESPR 4.0M
- NCV 405.1K
- Earning Date
- ESPR 03-04-2025
- NCV 01-01-0001
- Dividend Yield
- ESPR N/A
- NCV 12.48%
- EPS Growth
- ESPR N/A
- NCV N/A
- EPS
- ESPR N/A
- NCV N/A
- Revenue
- ESPR $332,314,000.00
- NCV N/A
- Revenue This Year
- ESPR $5.51
- NCV N/A
- Revenue Next Year
- ESPR $1.42
- NCV N/A
- P/E Ratio
- ESPR N/A
- NCV N/A
- Revenue Growth
- ESPR 185.66
- NCV N/A
- 52 Week Low
- ESPR $1.47
- NCV $2.84
- 52 Week High
- ESPR $3.94
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- ESPR 34.95
- NCV 31.29
- Support Level
- ESPR $1.47
- NCV $12.70
- Resistance Level
- ESPR $1.61
- NCV $12.99
- Average True Range (ATR)
- ESPR 0.13
- NCV 0.21
- MACD
- ESPR -0.01
- NCV -0.05
- Stochastic Oscillator
- ESPR 7.69
- NCV 21.74
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.